Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: Evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulators

Bioscience Reports

Volumn 32, Issue 3, 2012, Pages 281-297

  Leupold, Jörg Hendrik ^a,b   Asangani, Irfan Ahmed ^c   Mudduluru, Giridhar ^a,b   Allgayer, Heike ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Programmed cell death 4 (Pdcd4); Promoter; Transcription; Tumour suppressor; Zinc finger protein; Zinc finger binding protein 89 (ZBP 89)

Indexed keywords

CCAAT BINDING FACTOR; CIS ACTING ELEMENT; MESSENGER RNA; MITHRAMYCIN; PROGRAMMED CELL DEATH PROTEIN 4; REGULATOR PROTEIN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSCRIPTION FACTOR SP4; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER BINDING PROTEIN 89;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; EXON; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC TRANSFECTION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROGRAMMED CELL DEATH PROTEIN 4 GENE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATOR GENE; REPORTER GENE; SOLID TUMOR; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UPREGULATION; ZINC FINGER BINDING PROTEIN 89 GENE;

APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; BINDING SITES; CCAAT-BINDING FACTOR; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; PLICAMYCIN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN SYNTHESIS INHIBITORS; RNA-BINDING PROTEINS; SEQUENCE ANALYSIS, DNA; SP TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

EID: 84859450339     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20110045     Document Type: Article

References (73)

1. Soejima, H., Miyoshi, O., Yoshinaga, H., Masaki, Z., Ozaki, I., Kajiwara, S., Niikawa, N., Matsuhashi, S. and Mukai, T. (1999) Assignment of the programmed cell death 4 gene (PDCD4) to human chromosome band 10q24 by in situ hybridization. Cytogenet. Cell Genet. 87, 113-114 (Pubitemid 30021050)
2. Yoshinaga, H., Matsuhashi, S., Fujiyama, C. and Masaki, Z. (1999) Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody. Pathol. Int. 49, 1067-1077 (Pubitemid 30193505)
3. Stalberg, P., Lopez-Egido, J. R., Wang, S., Gobl, A., Oberg, K. and Skogseid, B. (2001) Differentially expressed cDNAs in PLCbeta3-induced tumor suppression in a human endocrine pancreatic tumor cell line: activation of the human mismatch repair protein 3 gene. Biochem. Biophys. Res. Commun. 281, 227-231 (Pubitemid 32924423)
4. Chen, Y., Knosel, T., Kristiansen, G., Pietas, A., Garber, M. E., Matsuhashi, S., Ozaki, I. and Petersen, I. (2003) Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J. Pathol. 200, 640-646 (Pubitemid 36987314)
5. Kang, M. J., Ahn, H. S., Lee, J. Y., Matsuhashi, S. and Park, W. Y. (2002) Up-regulation of PDCD4 in senescent human diploid fibroblasts. Biochem. Biophys. Res. Commun. 293, 617-621 (Pubitemid 34694254)
6. Azzoni, L., Zatsepina, O., Abebe, B., Bennett, I. M., Kanakaraj, P. and Perussia, B. (1998) Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J. Immunol. 161, 3493-3500
7. Ozpolat, B., Akar, U., Steiner, M., Zorrilla-Calancha, I., Tirado-Gomez, M., Colburn, N., Danilenko, M., Kornblau, S. and Berestein, G. L. (2007) Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Mol. Cancer Res. 5, 95-108
8. Matsuhashi, S., Narisawa, Y., Ozaki, I. and Mizuta, T. (2007) Expression patterns of programmed cell death 4 protein in normal human skin and some representative skin lesions. Exp. Dermatol. 16, 179-184 (Pubitemid 46242959)
9. Jansen, A. P., Camalier, C. E., Stark, C. and Colburn, N. H. (2004) Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol. Cancer Ther. 3, 103-110 (Pubitemid 39193684)
10. Carinci, F., Lo Muzio, L., Piattelli, A., Rubini, C., Chiesa, F., Ionna, F., Palmieri, A., Maiorano, E., Pastore, A., Laino, G. et al. (2005) Potential markers of tongue tumor progression selected by cDNA microarray. Int. J. Immunopathol. Pharmacol. 18, 513-524 (Pubitemid 41532366)
11. Zhang, Y., Ohyashiki, J. H., Takaku, T., Shimizu, N. and Ohyashiki, K. (2006) Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection. Br. J. Cancer 94, 599-608 (Pubitemid 43289766)
12. Wen, Y. H., Shi, X., Chiriboga, L., Matsahashi, S., Yee, H. and Afonja, O. (2007) Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol. Rep. 18, 1387-1393
13. Gao, F., Zhang, P., Zhou, C., Li, J., Wang, Q., Zhu, F., Ma, C., Sun, W. and Zhang, L. (2007) Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Oncol. Rep. 17, 123-128
14. Fang, W., Li, X., Jiang, Q., Liu, Z., Yang, H., Wang, S., Xie, S., Liu, Q., Liu, T., Huang, J. et al. (2008) Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J. Transl. Med. 6, 32
15. Mudduluru, G., Medved, F., Grobholz, R., Jost, C., Gruber, A., Leupold, J. H., Post, S., Jansen, A., Colburn, N. H. and Allgayer, H. (2007) Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 110, 1697-1707 (Pubitemid 47558956)
16. Li, J., Fu, H., Xu, C., Tie, Y., Xing, R., Zhu, J., Qin, Y., Sun, Z. and Zheng, X. (2010) miR-183 inhibits TGF-β1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 10, 354
17. Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S. and Allgayer, H. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136 (Pubitemid 351485639)
18. Chen, Y., Liu, W., Chao, T., Zhang, Y., Yan, X., Gong, Y., Qiang, B., Yuan, J., Sun, M. and Peng, X. (2008) MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett. 272, 197-205
19. Onishi, Y., Hashimoto, S. and Kizaki, H. (1998) Cloning of the TIS gene suppressed by topoisomerase inhibitors. Gene 215, 453-459 (Pubitemid 28382949)
20. Schlichter, U., Burk, O., Worpenberg, S. and Klempnauer, K. H. (2001) The chicken Pdcd4 gene is regulated by v-Myb. Oncogene 20, 231-239 (Pubitemid 32150268)
21. Appl, H. and Klempnauer, K. H. (2002) Targeted disruption of c-myb in the chicken pre B-cell line DT40. Oncogene 21, 3076-3081 (Pubitemid 34522908)
22. Fan, H., Zhao, Z., Quan, Y., Xu, J., Zhang, J. and Xie, W. (2007) DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721. Eur. J. Gastroenterol. Hepatol. 19, 952-961 (Pubitemid 350287401)
23. Gao, F., Wang, X., Zhu, F., Wang, Q., Zhang, X., Guo, C., Zhou, C., Ma, C., Sun, W., Zhang, Y. et al. (2009) PDCD4 gene silencing in gliomas is associated with 5′CpG island methylation and unfavourable prognosis. J. Cell Mol. Med. 13, 4257-4267
24. Cheng, P. Y., Kagawa, N., Takahashi, Y. and Waterman, M. R. (2000) Three zinc finger nuclear proteins, Sp1, Sp3, and a ZBP-89 homologue, bind to the cyclic adenosine monophosphate-responsive sequence of the bovine adrenodoxin gene and regulate transcription. Biochemistry 39, 4347-4357 (Pubitemid 30212650)
25. Merchant, J. L., Iyer, G. R., Taylor, B. R., Kitchen, J. R., Mortensen, E. R., Wang, Z., Flintoft, R. J., Michel, J. B. and Bassel-Duby, R. (1996) ZBP-89, a Kruppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter. Mol. Cell. Biol. 16, 6644-6653 (Pubitemid 26389722)
26. Zhang, X., Diab, I. H. and Zehner, Z. E. (2003) ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1. Nucleic Acids Res. 31, 2900-2914 (Pubitemid 37442134)
27. Keates, A. C., Keates, S., Kwon, J. H., Arseneau, K. O., Law, D. J., Bai, L., Merchant, J. L., Wang, T. C. and Kelly, C. P. (2001) ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cells. J. Biol. Chem. 276, 43713-43722
28. Park, H., Shelley, C. S. and Arnaout, M. A. (2003) The zinc finger transcription factor ZBP-89 is a repressor of the human beta 2-integrin CD11b gene. Blood 101, 894-902 (Pubitemid 36139356)
29. Holley-Guthrie, E. A., Seaman, W. T., Bhende, P., Merchant, J. L. and Kenney, S. C. (2005) The Epstein-Barr virus protein BMRF1 activates gastrin transcription. J. Virol. 79, 745-755 (Pubitemid 40053857)
30. Law, G. L., Itoh, H., Law, D. J., Mize, G. J., Merchant, J. L. and Morris, D. R. (1998) Transcription factor ZBP-89 regulates the activity of the ornithine decarboxylase promoter. J. Biol. Chem. 273, 19955-19964 (Pubitemid 28377543)
31. Petrovic, I., Kovacevic-Grujicic, N. and Stevanovic, M. (2009) ZBP-89 and Sp3 down-regulate while NF-Y up-regulates SOX18 promoter activity in HeLa cells. Mol. Biol. Rep. 36, 993-1000
32. Feng, Y., Wang, X., Xu, L., Pan, H., Zhu, S., Liang, Q., Huang, B. and Lu, J. (2009) The transcription factor ZBP-89 suppresses p16 expression through a histone modification mechanism to affect cell senescence. FEBS J. 276, 4197-4206
33. Salmon, M., Owens, G. K. and Zehner, Z. E. (2009) Over-expression of the transcription factor, ZBP-89, leads to enhancement of the C2C12 myogenic program. Biochim. Biophys. Acta 1793, 1144-1155
34. Bai, L., Kao, J. Y., Law, D. J. and Merchant, J. L. (2006) Recruitment of ataxia-telangiectasia mutated to the p21(waf1) promoter by ZBP-89 plays a role in mucosal protection. Gastroenterology 131, 841-852 (Pubitemid 44307067)
35. Wang, Y., Kobori, J. A. and Hood, L. (1993) The ht beta gene encodes a novel CACCC box-binding protein that regulates T-cell receptor gene expression. Mol. Cell. Biol. 13, 5691-5701 (Pubitemid 23260671)
36. Yamada, A., Takaki, S., Hayashi, F., Georgopoulos, K., Perlmutter, R. M. and Takatsu, K. (2001) Identification and characterization of a transcriptional regulator for the lck proximal promoter. J. Biol. Chem. 276, 18082-18089
37. Hasegawa, T., Takeuchi, A., Miyaishi, O., Xiao, H., Mao, J. and Isobe, K. (2000) PTRF (polymerase I and transcript-release factor) is tissue-specific and interacts with the BFCOL1 (binding factor of a type-I collagen promoter) zinc-finger transcription factor which binds to the two mouse type-I collagen gene promoters. Biochem. J. 347, 55-59 (Pubitemid 30199040)
38. Malo, M. S., Mozumder, M., Zhang, X. B., Biswas, S., Chen, A., Bai, L. C., Merchant, J. L. and Hodin, R. A. (2006) Intestinal alkaline phosphatase gene expression is activated by ZBP-89. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G737-G746
39. Thimmarayappa, J., Sun, J., Schultz, L. E., Dejkhamron, P., Lu, C., Giallongo, A., Merchant, J. L. and Menon, R. K. (2006) Inhibition of growth hormone receptor gene expression by saturated fatty acids: role of Kruppel-like zinc finger factor, ZBP-89. Mol. Endocrinol. 20, 2747-2760 (Pubitemid 44834327)
40. Moran, A., Iniesta, P., de Juan, C., Garcia-Aranda, C., Diaz-Lopez, A. and Benito, M. (2005) Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors. Cancer Res. 65, 3811-3814 (Pubitemid 40616360)
41. Bai, L., Yoon, S. O., King, P. D. and Merchant, J. L. (2004) ZBP-89-induced apoptosis is p53-independent and requires JNK. Cell Death Differ. 11, 663-673 (Pubitemid 38786714)
42. Bai, L. and Merchant, J. L. (2001) ZBP-89 promotes growth arrest through stabilization of p53. Mol. Cell. Biol. 21, 4670-4683
43. Dikic, I., Batzer, A. G., Blaikie, P., Obermeier, A., Ullrich, A., Schlessinger, J. and Margolis, B. (1995) Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain. J. Biol. Chem. 270, 15125-15129
44. Schewe, D., Biller, T., Maurer, G., Asangani, I., Leupold, J., Lengyel, E., Post, S. and Allgayer, H. (2005) Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2A-related factor binding to different regions of the urokinase receptor Gene in resected colorectal cancers. Clin. Cancer Res. 11, 8538-8548 (Pubitemid 43005898)
45. Esteller, M. (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8, 286-298
46. Kaczynski, J., Cook, T. and Urrutia, R. (2003) Sp1- and Kruppel-like transcription factors. Genome Biol. 4, 206
47. Wu, Y., Zhang, X., Salmon, M. and Zehner, Z. E. (2007) The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression. Genes Cells 12, 905-918 (Pubitemid 47261986)
48. Shibahara, K., Asano, M., Ishida, Y., Aoki, T., Koike, T. and Honjo, T. (1995) Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene 166, 297-301
49. Allgayer, H. (2010) Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit. Rev. Oncol. Hematol. 73, 185-191
50. Afonja, O., Juste, D., Das, S., Matsuhashi, S. and Samuels, H. H. (2004) Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23, 8135-8145 (Pubitemid 39531854)
51. Zhang, Z. and DuBois, R. N. (2001) Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene 20, 4450-4456 (Pubitemid 32772427)
52. Carayol, N., Katsoulidis, E., Sassano, A., Altman, J. K., Druker, B. J. and Platanias, L. C. (2008) Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway. J. Biol. Chem. 283, 8601-8610
53. Safe, S. and Abdelrahim, M. (2005) Sp transcription factor family and its role in cancer. Eur. J. Cancer 41, 2438-2448 (Pubitemid 41540621)
54. Zhou, Z., Lafleur, E. A., Koshkina, N. V., Worth, L. L., Lester, M. S. and Kleinerman, E. S. (2005) Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity. Mol. Cancer Res. 3, 685-691 (Pubitemid 43042998)
55. Wu, J., Xue, L., Weng, M., Sun, Y., Zhang, Z., Wang, W. and Tong, T. (2007) Sp1 is essential for p16 expression in human diploid fibroblasts during senescence. PLoS ONE 2, e164
56. Kim, H. S. and Lim, I. K. (2009) Phosphorylated extracellular signal-regulated protein kinases 1 and 2 phosphorylate Sp1 on serine 59 and regulate cellular senescence via transcription of p21Sdi1/Cip1/Waf1. J. Biol. Chem. 284, 15475-15486
57. Wei, D., Wang, L., He, Y., Xiong, H. Q., Abbruzzese, J. L. and Xie, K. (2004) Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res. 64, 2030-2038 (Pubitemid 38339450)
58. Abdelrahim, M. and Safe, S. (2005) Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol. Pharmacol. 68, 317-329 (Pubitemid 41058295)
59. Zhang, C. Z., Chen, G. G. and Lai, P. B. (2010) Transcription factor ZBP-89 in cancer growth and apoptosis. Biochim. Biophys. Acta 1806, 36-41
60. Yang, H. S., Knies, J. L., Stark, C. and Colburn, N. H. (2003) Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22, 3712-3720 (Pubitemid 36760733)
61. Cmarik, J. L., Min, H., Hegamyer, G., Zhan, S., Kulesz-Martin, M., Yoshinaga, H., Matsuhashi, S. and Colburn, N. H. (1999) Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc. Natl. Acad. Sci. U.S.A. 96, 14037-14042
62. Jansen, A. P., Camalier, C. E. and Colburn, N. H. (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res. 65, 6034-6041 (Pubitemid 40994387)
63. Bai, L. and Merchant, J. L. (2007) ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrate. Biochem. Biophys. Res. Commun. 359, 817-821 (Pubitemid 46899025)
64. Bai, L. and Merchant, J. L. (2000) Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells. J. Biol. Chem. 275, 30725-30733
65. Borghaei, R. C. and Chambers, M. (2009) Expression of transcription factor zinc-binding protein-89 (ZBP-89) is inhibited by inflammatory cytokines. Pathol. Lab. Med. Int. 1, 7-12
66. Yasuda, M., Schmid, T., Rubsamen, D., Colburn, N. H., Irie, K. and Murakami, A. (2010) Downregulation of programmed cell death 4 by inflammatory conditions contributes to the generation of the tumor promoting microenvironment. Mol. Carcinog. 49, 837-848
67. Dawson, M. I., Park, J. H., Chen, G., Chao, W., Dousman, L., Waleh, N., Hobbs, P. D., Jong, L., Toll, L., Zhang, X. et al. (2001) Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: a potential role for trans-RA-induced ZBP-89 in ODC inhibition. Int. J. Cancer 91, 8-21
68. Chen, G. G., Chan, U. P., Bai, L. C., Fung, K. Y., Tessier, A., To, A. K., Merchant, J. L. and Lai, P. B. (2009) ZBP-89 reduces the cell death threshold in hepatocellular carcinoma cells by increasing caspase-6 and S phase cell cycle arrest. Cancer Lett. 283, 52-58
69. Law, D. J., Tarle, S. A. and Merchant, J. L. (1998) The human ZBP-89 homolog, located at chromosome 3q21, represses gastrin gene expression. Mamm. Genome 9, 165-167 (Pubitemid 28165388)
70. Afonja, O., Juste, D., Das, S., Matsuhashi, S. and Samuels, H. (2004) Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23, 8135-8145 (Pubitemid 39531854)
71. To, A. K., Chen, G. G., Chan, U. P., Ye, C., Yun, J. P., Ho, R. L., Tessier, A., Merchant, J. L. and Lai, P. B. (2011) ZBP-89 enhances Bak expression and causes apoptosis in hepatocellular carcinoma cells. Biochim. Biophys. Acta 1813, 222-230
72. Zhang, H., Ozaki, I., Mizuta, T., Hamajima, H., Yasutake, T., Eguchi, Y., Ideguchi, H., Yamamoto, K. and Matsuhashi, S. (2006) Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25, 6101-6112 (Pubitemid 44562408)
73. Tomimaru, Y., Eguchi, H., Nagano, H., Wada, H., Tomokuni, A., Kobayashi, S., Marubashi, S., Takeda, Y., Tanemura, M., Umeshita, K. et al. (2010) MicroRNA-21 induces resistance to the anti-tumour effect of interferon-alpha/5- fluorouracil in hepatocellular carcinoma cells. Br. J. Cancer 103, 1617-1626